NCT05199792View on ClinicalTrials.gov

Efficacy of Gadoterate Meglumine in Diagnosis of Vascular Diseases Using MRA MRA

CompletedOBSERVATIONAL
Enrollment

65

Participants

Timeline

Start Date

June 2, 2017

Primary Completion Date

December 31, 2019

Study Completion Date

January 1, 2020

Conditions
Vascular Diseases
Interventions
DIAGNOSTIC_TEST

Dotarem

(Dotarem) (0.4 ml/kg (0.2 mmol/kg))

Trial Locations (1)

60611

Yasmeen Khan, Chicago

All Listed Sponsors
lead

Northwestern University

OTHER

NCT05199792 - Efficacy of Gadoterate Meglumine in Diagnosis of Vascular Diseases Using MRA MRA | Biotech Hunter | Biotech Hunter